Welcome to our dedicated page for Willis Towers SEC filings (Ticker: WTW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Willis Towers Watson Public Limited Company filings document regulatory disclosures for an Ireland-incorporated advisory, broking and solutions company with ordinary shares listed on Nasdaq. The record includes Form 8-K reports for quarterly and annual results, Regulation FD materials, non-GAAP reconciliations and amended earnings disclosures.
Proxy materials describe board matters, executive compensation and shareholder voting. Other material-event filings cover definitive agreements, financing arrangements including a delayed-draw term loan facility, registered security information and capital-structure disclosures tied to WTW's operating businesses and acquisition activity.
Tomczyk Fredric J reported acquisition or exercise transactions in this Form 4 filing.
Willis Towers Watson director Fredric J. Tomczyk reported receiving a grant of 925.014 restricted share units, which represent the right to receive ordinary shares of the company. The award was recorded at a price of $0.00 per share as equity compensation, not a market purchase.
The RSUs vest in full on the earlier of the one-year anniversary of the grant date and the company’s 2027 Annual General Meeting of Shareholders. Following this grant, Tomczyk’s reported direct holdings total 2,272.034 ordinary shares, including the RSUs.
WILLIS TOWERS WATSON PLC director Michelle R. Swanback received an equity award in the form of 925.014 ordinary shares on 2026-05-20, recorded at a price of $0.0000 per share as a grant, not a market purchase. Following this award, her directly held ordinary shares total 2,848.034. The award is structured as restricted share units that convert into ordinary shares and will vest in full on the earlier of the one-year anniversary of the grant date or the company’s 2027 Annual General Meeting of Shareholders.
REILLY PAUL C reported acquisition or exercise transactions in this Form 4 filing.
Willis Towers Watson plc director Paul C. Reilly reported a new equity award and updated holdings. He received 1,318.638 restricted share units, which are rights to receive ordinary shares at no cash cost. After this grant, he holds 3,146.395 ordinary shares directly and 48 shares indirectly through a revocable trust.
The restricted share units will vest in full on the earlier of the one-year anniversary of the grant date and the company’s 2027 Annual General Meeting of Shareholders, aligning his compensation with future company performance over that period.
Hunt Jacqueline reported acquisition or exercise transactions in this Form 4 filing.
Willis Towers Watson plc director Jacqueline Hunt reported receiving a grant of 925.014 restricted share units (RSUs), each representing one ordinary share. The award was recorded at a price of $0.00 per share as part of her compensation. These RSUs will vest in full on the earlier of the one-year anniversary of the grant date and the company’s 2027 Annual General Meeting of Shareholders. Following this grant, Hunt holds 2,272.034 ordinary shares directly.
Hammond Michael P. reported acquisition or exercise transactions in this Form 4 filing.
WILLIS TOWERS WATSON PLC director receives equity award through a grant of 925.014 restricted share units (RSUs) to Michael P. Hammond. These RSUs represent the right to receive ordinary shares and will vest in full on the earlier of the one-year anniversary of the grant date and the company’s 2027 Annual General Meeting of Shareholders. Following this grant, Hammond holds a total of 3,089.034 ordinary shares, including the awarded RSUs, all reported as directly owned.
Chipman Stephen M. reported acquisition or exercise transactions in this Form 4 filing.
Willis Towers Watson plc director Stephen M. Chipman received an award of 925.014 restricted share units (RSUs). These RSUs represent the right to receive ordinary shares and carry a nominal value of $0.000304635 per share. They will vest in full on the earlier of the one-year anniversary of the grant date and the company’s 2027 Annual General Meeting of Shareholders. Following this equity grant, Chipman’s direct holdings reported in this filing increased to a total of 2,272.034 ordinary shares, reflecting routine share-based compensation rather than an open-market purchase or sale.
Chima Fumbi F. reported acquisition or exercise transactions in this Form 4 filing.
Willis Towers Watson PLC director Fumbi F. Chima received an equity grant in the form of restricted share units. On May 20, 2026, Chima was awarded 1,417.043 ordinary-share RSUs at a price of $0.0000 per share, increasing direct holdings to 4,314.733 ordinary shares in total.
The RSUs represent the right to receive Willis Towers Watson ordinary shares with a nominal value of $0.000304635 per share. They vest in full on the earlier of the one-year anniversary of the grant date and the company’s 2027 Annual General Meeting of Shareholders, making this a routine, compensation-related award rather than a market purchase.
Beale Inga K reported acquisition or exercise transactions in this Form 4 filing.
Willis Towers Watson plc director Inga K. Beale received an equity grant of 925.014 restricted share units (RSUs). The RSUs represent the right to receive the company’s ordinary shares at no purchase price and will vest in full on the earlier of the one-year anniversary of the May 20, 2026 grant date and the company’s 2027 Annual General Meeting of Shareholders. After this award, Beale holds a total of 2,848.034 ordinary shares, including the granted RSUs.
Willis Towers Watson reported the results of its 2026 Annual General Meeting of Shareholders, where all proposals were approved. Shareholder turnout was high, with 87,424,851 ordinary shares represented, about 92.8% of the 94,203,101 shares outstanding and entitled to vote as of March 23, 2026.
Shareholders elected all director nominees and ratified, on an advisory basis, Deloitte & Touche LLP and Deloitte Ireland LLP as auditors, authorizing the Board’s Audit Committee to set their remuneration. They also approved, on an advisory basis, the compensation of named executive officers.
In addition, shareholders renewed the Board’s authority under Irish law to issue shares and to opt out of statutory pre-emption rights for rights issues and certain issuances up to approximately 20% of issued share capital. They approved the WTW Amended and Restated Employee Share Purchase Plan, including an increase in shares authorized for issuance under the plan.
Willis Towers Watson director Michael P. Hammond reported a tax-related share disposition tied to restricted share unit vesting. On the vesting and settlement of 709.655 restricted share units granted on May 15, 2025, 340.635 ordinary shares were withheld by the company at a price of $247.64 per share to cover tax obligations. After this non-market transaction, Hammond directly holds 2,164.020 ordinary shares.